ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Amgen, Inc.
(NQ:
AMGN
)
99.08
USD
+1.66 (+1.70%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
98.72
Bid (Size)
99.08 (10100)
Ask (Size)
99.10 (2000)
Prev. Close
97.42
Today's Range
98.50 - 100.09
52wk Range
70.52 - 114.95
Shares Outstanding
749,976,556
Dividend Yield
1.68%
Featured News
More News
Income hunters: Bank on this dividend stock play
June 13, 2013
Paying a dividend vs. buying back shares is a debate investors should feel fortunate about. Companies with such a choice are fundamentally sound, and those that can do both simultaneously are even...
Read More
category
Earnings
,
VZ
,
T
, and 59 more.
from
MarketWatch
3 ways to play the biotech boom
June 03, 2013
If you want to join in the biotech boom, these funds offer varying levels of risk and protection, writes Jeff Reeves.
Read More
category
REGN
,
Biotechnology
,
Opinion
, and 24 more.
from
MarketWatch
Featured News
Read More
X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 14
May 07, 2013
category
MRO
,
MSFT
,
AMGN
, and 2 more.
from
Minyanville Headlines
Stock Upgrades: Trulia Is the Real Deal
May 01, 2013
category
AMGN
from
Minyanville Headlines
Biotech’s latest rally: exuberance or execution?
April 26, 2013
category
Household Products
,
Biotechnology
,
NBI
, and 11 more.
from
MarketWatch
Minyanville's T3 Morning Market Call: Sector Rotation Continues to Fuel Macro Uptrend
April 25, 2013
category
MSFT
,
INTC
,
AMGN
, and 1 more.
from
Minyanville Headlines
Stock Downgrades: Apple Gets Totally Turned Over
April 24, 2013
category
DFS
,
T
,
AMGN
, and 1 more.
from
Minyanville Headlines
Stock futures slip; China, Germany growth fears
April 23, 2013
category
YUM
,
Computer Software
,
T
, and 15 more.
from
MarketWatch
More News
Read More
Barron's Recap: Midyear Roundtable
June 17, 2013
category
amgen
,
BIG
,
Benzinga
, and 14 more.
from
Latest Articles from Benzinga.com
The Real Story Behind AMGN, BIDU, HCP and LYB
June 17, 2013
from
Marketwired News Releases
Amgen share buybacks, drugs may fuel more stock gains - Barron's
June 16, 2013
category
companyNews
from
Reuters: Company News
New Amgen Drug Receives FDA Approval (AMGN)
June 13, 2013
category
amgen
,
amgn
,
Dividend Stocks
from
Dividend Daily
FDA Approves Amgen's (AMGN) XGEVA for GCTB
June 13, 2013
from
StreetInsider.com News Articles
FDA Approves Amgen's XGEVA® (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
June 13, 2013
from
PR Newswire
FDA Issues Approval for Xgeva, Marketed by Amgen
June 13, 2013
category
Benzinga
,
AMGN
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
Needham & Company Sees 150% Upside in Cytokinetics (CYTK) after Expanded Amgen (AMGN) Deal
June 13, 2013
from
StreetInsider.com News Articles
Amgen’s AMG-386 Still Not Meeting FDA Standards (AMGN)
June 12, 2013
category
amgn
,
Dividend Stocks
from
Dividend Daily
RBC Says Amgen's AMG-386 Will Need to See Increases in Overall Survival Benefits Before FDA Approval
June 12, 2013
category
Benzinga
,
AMGN
,
News
, and 3 more.
from
Latest Articles from Benzinga.com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
2
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
3
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster
4
Tech News: Netflix, Inc Signs Largest Deal in Its History With DreamWorks Animation Skg Inc
Josh Wolonick
5
Random Thoughts: World Peace Breaks Out for Global Stock Markets
Todd Harrison
See All Articles
»